Special Issue "Disentangling Clinical and Biological Heterogeneity in Huntington’s Disease: Implications for Clinical Trials"

A special issue of Journal of Clinical Medicine (ISSN 2077-0383). This special issue belongs to the section "Nuclear Medicine & Radiology".

Deadline for manuscript submissions: 15 April 2023 | Viewed by 766

Special Issue Editor

Centro de Investigación en Red-Enfermedades Neurodegenerativas (CIBERNED), Barcelona, Spain
Interests: radiology; neuroimaging; data science; neurodegenerative diseases; biomarkers

Special Issue Information

Dear Colleagues,

Huntington’s disease (HD) experience progressive motor, cognitive and neuropsychiatric symptoms that lead to a devastating loss of functional independence. However, there is substantial heterogeneity across HD patients regarding the longitudinal evolution of these symptoms. Some of them show cognitive predominance, others neuropsychiatric, and some of them will only experience motor symptoms until a late disease stage. Being able to characterize and predict this clinical heterogeneity is crucial to optimize treatment strategies. For that, neuroimaging and biomarker research is needed to better understand the origin of these divergent phenotypes. This issue will focus on delineating the set of clinical, neuroimaging and biomarker profiles of HD patients. Moreover, we will aim to provide practical tools to classify HD patients in clinical trials targeting both motor and non-motor symptoms.

Dr. Frederic Sampedro
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Clinical Medicine is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • Huntington’s disease
  • Non-motor symptoms
  • Neuroimaging
  • Biomarkers
  • Phenotype heterogeneity

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:

Research

Article
The Comprehensive Analysis of Motor and Neuropsychiatric Symptoms in Patients with Huntington’s Disease from China: A Cross-Sectional Study
J. Clin. Med. 2023, 12(1), 206; https://doi.org/10.3390/jcm12010206 - 27 Dec 2022
Viewed by 551
Abstract
Huntington’s disease (HD) is an autosomal dominant inherited neurodegenerative disorder caused by CAG repeats expansion. There is a paucity of comprehensive clinical analysis in Chinese HD patients due to the low prevalence of HD in Asia. We aimed to comprehensively describe the motor, [...] Read more.
Huntington’s disease (HD) is an autosomal dominant inherited neurodegenerative disorder caused by CAG repeats expansion. There is a paucity of comprehensive clinical analysis in Chinese HD patients due to the low prevalence of HD in Asia. We aimed to comprehensively describe the motor, neuropsychiatric symptoms, and functional assessment in patients with HD from China. A total of 205 HD patients were assessed by the Unified Huntington’s Disease Rating Scale (UHDRS), the short version of Problem-Behavior Assessment (PBA-s), Hamilton Depression Scale (HAMD) and Beck Depression Inventory (BDI). Multivariate logistic regression analysis was used to explore the independent variables correlated with neuropsychiatric subscales. The mean age of motor symptom onset was 41.8 ± 10.0 years old with a diagnostic delay of 4.3 ± 3.8 years and a median CAG repeats of 44. The patients with a positive family history had a younger onset and larger CAG expansion than the patients without a family history (p < 0.05). There was a significant increase in total motor score across disease stages (p < 0.0001). Depression (51%) was the most common neuropsychiatric symptom at all stages, whereas moderate to severe apathy commonly occurred in advanced HD stages. We found lower functional capacity and higher HAMD were independently correlated with irritability; higher HAMD and higher BDI were independently correlated with affect; male sex and higher HAMD were independently correlated with apathy. In summary, comprehensive clinical profile analysis of Chinese HD patients showed not only chorea-like movement, but psychiatric symptoms were outstanding problems and need to be detected early. Our study provides the basis to guide clinical practice, especially in practical diagnostic and management processes. Full article
Show Figures

Figure 1

Back to TopTop